Exploration of Targeted Anti-tumor Therapy

Open Access Case Report

Solitary fibrous tumor of the lung: diagnostic challenges and surgical management

Vasileios Leivaditis ... Manfred Dahm

Published: April 21, 2026 Explor Target Antitumor Ther. 2026;7:1002367

DOI: https://doi.org/10.37349/etat.2026.1002367

Full Text PDF

96 14 0

Open Access Original Article

Lorlatinib in advanced ALK-positive NSCLC after prior progression on ALK inhibitors: real-world experience in Russia

Sergey V. Orlov ... Evgeny N. Imyanitov

Published: April 16, 2026 Explor Target Antitumor Ther. 2026;7:1002366

DOI: https://doi.org/10.37349/etat.2026.1002366

Full Text PDF

389 18 0

Open Access Original Article

Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC

Yuki Oda ... Kiyohide Fujimoto

Published: April 13, 2026 Explor Target Antitumor Ther. 2026;7:1002365

DOI: https://doi.org/10.37349/etat.2026.1002365

Full Text PDF

536 14 0

Open Access Original Article

Disrupting the TGF-β-regulated epithelial-mesenchymal transition, apoptotic and autophagic phenotypes of 3D glioblastoma spheroids via glycolytic inhibition

Maellis Payet-Desruisseaux ... Borhane Annabi

Published: March 30, 2026 Explor Target Antitumor Ther. 2026;7:1002364

DOI: https://doi.org/10.37349/etat.2026.1002364

This article belongs to the special issue Novel Precision Medicine Approaches to Brain Tumors (Primary and Metastatic)

Full Text PDF

652 20 0

Open Access Original Article

CHD4 and NOX4 expression in thyroid tumor tissues

Salma Fenniche ... Rabii Ameziane El Hassani

Published: March 25, 2026 Explor Target Antitumor Ther. 2026;7:1002363

DOI: https://doi.org/10.37349/etat.2026.1002363

Full Text PDF

707 27 0

Open Access Original Article

Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort

Mehrshad Alirezaei Farahani ... Marjan Mansourian

Published: March 20, 2026 Explor Target Antitumor Ther. 2026;7:1002362

DOI: https://doi.org/10.37349/etat.2026.1002362

Full Text PDF

934 21 0

Open Access Review

Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer

Ogochukwu O. Izuegbuna

Published: March 09, 2026 Explor Target Antitumor Ther. 2026;7:1002361

DOI: https://doi.org/10.37349/etat.2026.1002361

This article belongs to the special issue Breaking Boundaries in Breast Cancer Care: Emerging Controversies and Innovation in Surgical and Medical Approaches

Full Text PDF

1592 33 0

Open Access Systematic Review

Comparison of weekly docetaxel regimens in prostate cancer: a systematic review and frequentist network meta-analysis

Shree Rath ... Amar Lal

Published: February 27, 2026 Explor Target Antitumor Ther. 2026;7:1002360

DOI: https://doi.org/10.37349/etat.2026.1002360

Full Text PDF

1398 33 0

Open Access Mini Review

Benign, persistent, and invasive: mechanistic and translational approaches to middle‑ear cholesteatoma

Pinelopi Samara ... Ioannis Athanasopoulos

Published: February 24, 2026 Explor Target Antitumor Ther. 2026;7:1002359

DOI: https://doi.org/10.37349/etat.2026.1002359

Full Text PDF

1328 33 0

Open Access Review

Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution

George Anderson

Published: February 13, 2026 Explor Target Antitumor Ther. 2026;7:1002358

DOI: https://doi.org/10.37349/etat.2026.1002358

Full Text PDF

1718 27 0

Open Access Perspective

Application of explainable artificial intelligence integrating with electronic health record in oncology

Yuhan Yang, Xici Liu

Published: February 04, 2026 Explor Target Antitumor Ther. 2026;7:1002357

DOI: https://doi.org/10.37349/etat.2026.1002357

Full Text PDF

1969 16 1

Open Access Editorial

The critical need for robust decision support in the era of precision cancer therapeutics

Maurie Markman

Published: January 22, 2026 Explor Target Antitumor Ther. 2026;7:1002356

DOI: https://doi.org/10.37349/etat.2026.1002356

Full Text PDF

946 41 0

Open Access Review

Next-generation nanocarriers for precision antitumor therapy: from passive targeting to intelligent response

Dilpreet Singh, Akshay Kumar

Published: December 28, 2025 Explor Target Antitumor Ther. 2025;6:1002355

DOI: https://doi.org/10.37349/etat.2025.1002355

Full Text PDF

2680 47 5

Open Access Review

Therapeutic properties of plant-derived prebiotics in melanoma

Emily Kay ... Seema Nair Parvathy

Published: December 19, 2025 Explor Target Antitumor Ther. 2025;6:1002354

DOI: https://doi.org/10.37349/etat.2025.1002354

Full Text PDF

1910 24 1

Open Access Letter to the Editor

Conceptualization of fibroblast growth factor receptor 1 targeting nanomedicines

Yilin Ma ... Zhengwei Huang

Published: December 17, 2025 Explor Target Antitumor Ther. 2025;6:1002353

DOI: https://doi.org/10.37349/etat.2025.1002353

Full Text PDF

747 23 0

Open Access Protocol

Optimizing procedures for ocular radiation injury studies in the tree shrew

Lauren A. Dalvin ... Gavin W. Roddy

Published: December 01, 2025 Explor Target Antitumor Ther. 2025;6:1002352

DOI: https://doi.org/10.37349/etat.2025.1002352

Full Text PDF

1044 23 0

Open Access Mini Review

Unmasking the microbiome: the hidden role of gut bacteria in the pathogenesis of colorectal cancer and its prevention strategies

Tallha W. Khawaja ... Yujiang Fang

Published: November 24, 2025 Explor Target Antitumor Ther. 2025;6:1002351

DOI: https://doi.org/10.37349/etat.2025.1002351

Full Text PDF

2317 25 0

Open Access Review

Cancer vaccines: advances, hurdles, and future directions

Panagiotis J. Vlachostergios

Published: November 24, 2025 Explor Target Antitumor Ther. 2025;6:1002350

DOI: https://doi.org/10.37349/etat.2025.1002350

This article belongs to the special issue Cancer Vaccines: From Basic Innovations to Clinical Translation

Full Text PDF

3098 117 5

Open Access Review

Smart nanofluidic systems powered by DNA origami for targeted intracellular delivery: a newer approach

Dilpreet Singh ... Neena Bedi

Published: November 19, 2025 Explor Target Antitumor Ther. 2025;6:1002349

DOI: https://doi.org/10.37349/etat.2025.1002349

Full Text PDF

4484 61 0

Open Access Review

Role of microbiota in the outcome of immune checkpoint inhibition therapy of cancer

Ger T. Rijkers ... Frans J. van Overveld

Published: November 18, 2025 Explor Target Antitumor Ther. 2025;6:1002348

DOI: https://doi.org/10.37349/etat.2025.1002348

Full Text PDF

2190 25 1